Cite
HARVARD Citation
Spring, L. et al. (2017). Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Oncologist. pp. 1039-1048. [Online].